These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 18602252)

  • 21. First description of KPC-2-producing Klebsiella oxytoca in Brazil.
    Almeida AC; Cavalcanti FL; Martins WM; Vilela MA; Gales AC; Morais Junior MA; Morais MM
    Antimicrob Agents Chemother; 2013 Aug; 57(8):4077-8. PubMed ID: 23752512
    [TBL] [Abstract][Full Text] [Related]  

  • 22. First detection of plasmid-encoded blaOXY beta-lactamase.
    González-López JJ; Coelho A; Larrosa MN; Lavilla S; Bartolomé R; Prats G
    Antimicrob Agents Chemother; 2009 Jul; 53(7):3143-6. PubMed ID: 19380592
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of TolC in Klebsiella oxytoca resistance to antibiotics.
    Fenosa A; Fusté E; Ruiz L; Veiga-Crespo P; Vinuesa T; Guallar V; Villa TG; Viñas M
    J Antimicrob Chemother; 2009 Apr; 63(4):668-74. PubMed ID: 19240073
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of contaminated aspiration tubes in nosocomial outbreak of Klebsiella pneumoniae producing SHV-2 and CTX-M-15 extended-spectrum beta-lactamases.
    Randrianirina F; Vedy S; Rakotovao D; Ramarokoto CE; Ratsitohaina H; Carod JF; Ratsima E; Morillon M; Talarmin A
    J Hosp Infect; 2009 May; 72(1):23-9. PubMed ID: 19282056
    [TBL] [Abstract][Full Text] [Related]  

  • 25. First occurrence of KPC-2-possessing Klebsiella pneumoniae in a Greek hospital and recommendation for detection with boronic acid disc tests.
    Tsakris A; Kristo I; Poulou A; Markou F; Ikonomidis A; Pournaras S
    J Antimicrob Chemother; 2008 Dec; 62(6):1257-60. PubMed ID: 18772158
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Complete sequences of two plasmids in a blaNDM-1-positive Klebsiella oxytoca isolate from Taiwan.
    Huang TW; Wang JT; Lauderdale TL; Liao TL; Lai JF; Tan MC; Lin AC; Chen YT; Tsai SF; Chang SC
    Antimicrob Agents Chemother; 2013 Aug; 57(8):4072-6. PubMed ID: 23752513
    [TBL] [Abstract][Full Text] [Related]  

  • 27. New Klebsiella oxytoca beta-lactamase genes bla(OXY-3) and bla(OXY-4) and a third genetic group of K oxytoca based on bla(OXY-3).
    Granier SA; Leflon-Guibout V; Goldstein FW; Nicolas-Chanoine MH
    Antimicrob Agents Chemother; 2003 Sep; 47(9):2922-8. PubMed ID: 12936995
    [TBL] [Abstract][Full Text] [Related]  

  • 28. New genetic environments of aac(6')-Ib-cr gene in a multiresistant Klebsiella oxytoca strain causing an outbreak in a pediatric intensive care unit.
    Ruiz E; Rezusta A; Sáenz Y; Rocha-Gracia R; Vinué L; Vindel A; Villuendas C; Azañedo ML; Monforte ML; Revillo MJ; Torres C
    Diagn Microbiol Infect Dis; 2011 Feb; 69(2):236-8. PubMed ID: 21251575
    [No Abstract]   [Full Text] [Related]  

  • 29. Klebsiellapneumoniae isolates possessing KPC beta-lactamase in Israel, Puerto Rico, Colombia and Greece.
    Hawser SP; Bouchillon SK; Hoban DJ; Hackel M; Johnson JL; Badal RE
    Int J Antimicrob Agents; 2009 Oct; 34(4):384-5. PubMed ID: 19560904
    [No Abstract]   [Full Text] [Related]  

  • 30. In vivo selection of an Escherichia coli isolate highly resistant to ciprofloxacin and ceftazidime: role of a 4-bp duplication in acrR and ampC overexpression.
    Corvec S; Lepelletier D; Reynaud A; Dauvergne S; Giraudeau C; Caroff N
    Int J Antimicrob Agents; 2008 Aug; 32(2):196-8. PubMed ID: 18571906
    [No Abstract]   [Full Text] [Related]  

  • 31. A VIM-1 metallo-beta-lactamase-producing Klebsiella pneumoniae clinical isolate in an acute hospital in Germany.
    Weile J; Ohler S; Schönthal S; Knabbe C
    Int J Antimicrob Agents; 2009 Apr; 33(4):389-91. PubMed ID: 19108993
    [No Abstract]   [Full Text] [Related]  

  • 32. Re: A VIM-1-metallo-beta-lactamase-producing Klebsiella pneumoniae clinical isolate in an acute hospital in Germany.
    Shah PM
    Int J Antimicrob Agents; 2009 Oct; 34(4):381. PubMed ID: 19502012
    [No Abstract]   [Full Text] [Related]  

  • 33. Mechanism of resistance of a highly carbapenem-resistant Klebsiella oxytoca isolate and comparison of susceptibility to five carbapenems.
    Sho T; Muratani T; Mizokami Y; Hamasuna R; Fujimoto N; Matsumoto T
    Int J Antimicrob Agents; 2012 Mar; 39(3):268-9. PubMed ID: 22226923
    [No Abstract]   [Full Text] [Related]  

  • 34. Emergence of extended-spectrum beta-lactamases in clinical isolates of Salmonella enterica in Tehran, Iran.
    Hamidian M; Tajbakhsh M; Walther-Rasmussen J; Zali MR
    Jpn J Infect Dis; 2009 Sep; 62(5):368-71. PubMed ID: 19762986
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Behaviour of ceftazidime towards beta-lactamases.
    Labia R; Beguin-Billecoq R; Guionie M
    J Antimicrob Chemother; 1981 Sep; 8 Suppl B():141-6. PubMed ID: 19810176
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clonal spread of KPC-2 carbapenemase-producing Klebsiella pneumoniae strains in Greece.
    Pournaras S; Protonotariou E; Voulgari E; Kristo I; Dimitroulia E; Vitti D; Tsalidou M; Maniatis AN; Tsakris A; Sofianou D
    J Antimicrob Chemother; 2009 Aug; 64(2):348-52. PubMed ID: 19525514
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genetic characterisation of CTX-M-15-producing Klebsiella pneumoniae and Escherichia coli strains isolated from stem cell transplant patients in Tunisia.
    Abbassi MS; Torres C; Achour W; Vinué L; Sáenz Y; Costa D; Bouchami O; Ben Hassen A
    Int J Antimicrob Agents; 2008 Oct; 32(4):308-14. PubMed ID: 18620848
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fluoroquinolone resistance in clinical isolates of Klebsiella oxytoca.
    Horii T; Osaki M; Muramatsu H
    Chemotherapy; 2008; 54(4):323-7. PubMed ID: 18698136
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Investigation of plasmid-mediated AmpC beta-lactamase types in Klebsiella spp. and Escherichia coli isolates resistant or intermediate to cefoxitin].
    Demirbakan H; Midilli K; Oğünç D; Ozen N; Ongüt G; Dağlar D; Mutlu D; Ozhak B; Colak D
    Mikrobiyol Bul; 2008 Oct; 42(4):545-51. PubMed ID: 19149075
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro and in vivo potency of polymyxin B against IMP-type metallo-beta-lactamase-producing Pseudomonas aeruginosa.
    Miyajima Y; Hiramatsu K; Mizukami E; Morinaga R; Ishii H; Shirai R; Kishi K; Tokimatsu I; Saikawa T; Kadota J
    Int J Antimicrob Agents; 2008 Nov; 32(5):437-40. PubMed ID: 18715759
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.